No Detail Found!

Optimization of Bacillus clausii on Apple Waste and its Synergistic Effects Against Pathogenic Bacteria

Author(s)
Faryal Kund Department of Allied Health Sciences, Iqra National University, Peshawar 25100, Pakistan
Faheem Ahmed Khan Department of Allied Health Sciences, Iqra National University, Peshawar 25100, Pakistan
Pashmina Department of Allied Health Sciences at Iqra National University, Peshawar 25100, Pakistan
Amir Afzal Khan Department of Medical Laboratory Technology, Riphah International University, Islamabad 44000, Pakistan
Irfan Ullah Department of Medical Laboratory Technology, Riphah International University, Islamabad 44000 , Pakistan
Abstract
The probiotic Bacillus clausii is good for human health. The ability to generate spores is one of its primary characteristics; the ensuing endurance to heat, acid, and salt ensures safe passage through the human gastrointestinal tract without cellular loss. The study is aimed at the optimization of Bacillus clausii on apple waste and its synergistic effects against pathogenic bacteria. Bacillus clausii has been taken from Abasyn University, Peshawar. Further, the subculturing, and biochemical characterization have been done using standard microbiological procedures. The optimization of Bacillus clausii is done using apple waste. Mueller Hinton Agar is used for the antimicrobial susceptibility assay as well as the synergistic effect between Salmonella and E. coli. Bacillus clausii is identified as Gram positive, showed a creamy white appearance, had rod shaped microorganism, and underwent various biochemical tests. It is found that the growth of Bacillus clausii is maximum at 37?, at pH 9, and a glucose concentration of 3gram with shaking conditions at 150 rpm. Moreover, Bacillus clausii showed resistance to cefotaxime, and cefixime, while highest sensitivity against ciprofloxacin and meropenem. After 24 hours of incubation, no bacterial inhibition is observed against Salmonella. No synergistic effect between E. coli and Bacillus clausii is observed against Salmonella typhi clinical isolates. In conclusion, Bacillus clausii grows at a maximum at a temperature of 37?, with a PH of 9, the glucose concentration is 3 grams. Moreover, no synergistic effect is observed against Salmonella typhi bacteria.
Publication Details
Page(s) 153-164
DOI DOI not available
Published Journal: The Sciencetech, Volume: 6, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
Bacillus clausii, Pathogenic bacteria, Apple Waste, Synergistic effects
References
Abbrescia A.,Palese L. L.,Papa S.,Gaballo A.,Alifano P.,Sardanelli M,A. M,Drugs M .2014 .Antibiotic sensitivity of Bacillus clausii strains in commercial preparation. Clinical Immunology, 1(2) : 102-110.
Ahire J. J.,Kashikar M. S.,Lakshmi S. G.,Madempudi R. .2020 .Identification and characterization of antimicrobial peptide produced by indigenously isolated Bacillus paralicheniformis UBBLi30 strain. , 10(3) : 112.
Batool N.,Shakir H. A.,Qazi J. I. .2015 .Comparative growth potential of different Bacillus species on fruit peels. Punjab Univ. J. Zool, 30(1) : 25-29.
Batool A.,Yunus N.,Yaqoob A. S. M. A.,Lone D. S.,Khalid A.,Ejaz H. A. S. A. N.,Ahmed Q. A. S. I. M. .2021 .Prevalence of Multi-Drug Resistant and Extensively Drug-Resistant Salmonella enterica Serovar Typhi Recovered from Pediatrics' Septicemia Patients in Lahore. Pakistan Journal of Medical and Health Sciences, 15(4) : 843-845.
Bauer A. W.,Kirby W. M. M.,Sherris J. C.,Turck M. .1966 .Antibiotic susceptibility testing by a standardized single disk method. American journal of clinical pathology, 45(4) : 493-496.
Dang H. T.,Tran D. M.,Phung D. M.,Bui A. T.,Vu Y. H.,Luong M. T.,Van Nguyen A. T. .2024 .Promising clinical and immunological efficacy of Bacillus clausii spore probiotics for supportive treatment of persistent diarrhea in children. Scientific Reports, 14(1) : 6422.
Elshaghabee F. M.,Rokana N.,Gulhane R. D.,Sharma C.,Panwar H. .2017 .Bacillus as potential probiotics: status, concerns, and future perspectives. Frontiers in microbiology, 8, : 1490.
Falagas M. E.,Koletsi P. K.,Bliziotis I. A. .2006 .The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. Journal of medical microbiology, 55(12) : 1619-1629.
Fanimo A. O.,Oduguwa O. O.,Alade A. A.,Ogunnaike T. O.,Adesehinwa A. K. .2003 .Growth performance, nutrient digestibility and carcass characteristic of growing rabbits fed cashew apple waste. Livestock Research for Rural Development, 15(8) : 1-8.
Haq ,Haq ,Javaid ,Zafar ,Ahmad ,Haq Momina. .2022 .MultiDrug Resistance of Escherichia coli (E. coli) Isolated from Clinical Isolates in District Peshawar Kp Pakistan. Pak. J. Med. Health Sci, 16 : 830-835.
Hoyles L.,Honda H.,Logan N. A.,Halket G.,La Ragione,McCartney R. M.,A. L. R. M. .2012 .Recognition of greater diversity of Bacillus species and related bacteria in human faeces. , 163(1) : 3-13.
Kabeer S.,Mushtaq Z. .2023 .Synergistic and antagonistic effects on antimicrobial properties of organic and aqueous extracts of Bacillus clausii KP10 in combination with conventional antibiotics. JAPS: Journal of Animal & Plant Sciences, 33(1) : .
Kageyama Y.,Takaki Y.,Shimamura S.,Nishi S.,Nogi Y.,Uchimura K.,Horikoshi K. .2007 .Intragenomic diversity of the V1 regions of 16S rRNA genes in high-alkaline protease-producing Bacillus clausii spp. Extremophiles, 11 : 597-603.
Lopetuso L. R.,Scaldaferri F.,Franceschi F.,Gasbarrini A. .2016 .Bacillus clausii and gut homeostasis: state of the art and future perspectives. Expert review of gastroenterology & hepatology, 10(8) : 943-948.
Muras A.,Romero M.,Mayer C.,Otero A. .2021 .Biotechnological applications of Bacillus licheniformis. Critical Reviews in Biotechnology, 41(4) : 609-627.
Mushtaq M.,Shuaib M.,Iqbal A.,Sufyan A.,Shah M.,Nawaz N. U. A.,Zeb U. .2024 .Antibacterial and Immuno-Modulatory Effects of Probiotics and Phytobiotics in Spent Rhode Island Red Layers. , : .
Nista E. C.,Candelli M.,Cremonini F.,Cazzato I. A.,Zocco M. A.,Franceschi F.,Gasbarrini A. .2004 .Bacillus clausii therapy to reduce side‐effects of anti‐Helicobacter pylori treatment: randomized, double‐blind, placebo controlled trial. Alimentary pharmacology & therapeutics, 20(10) : 1181-1188.
Oskouie S. F. G.,Tabandeh F.,Yakhchali B.,Eftekhar F. .2008 .Response surface optimization of medium composition for alkaline protease production by Bacillus clausii. Biochemical Engineering Journal, 39(1) : 37-42.
Paterson D. L.,Doi Y. .2007 .Editorial commentary: a step closer to extreme drug resistance (XDR) in gram-negative bacilli. Clinical infectious diseases, : 1179-1181.
Plomer M.,Perez III,Greifenberg M.,D. M. M. .2020 .Effect of Bacillus clausii capsules in reducing adverse effects associated with Helicobacter pylori eradication therapy: a randomized, doubleblind, controlled trial. Infectious Diseases and Therapy, 9 : 867-878.
Rani M. S.,Madar I. H.,Ogu H.,Tayubi G. I.,I. A. G. I. .2018 .Biochemical and phenotypic profiling of Bacillus clausii: a potent commercial probiotic. International Journal of Scientific Innovations, 5(03) : 099-106.
Rashmi B. S.,Gayathri D. .2017 .Molecular characterization of gluten hydrolysing Bacillus sp. and their efficacy and biotherapeutic potential as probiotics using Caco‐2 cell line. Journal of Applied Microbiology, 123(3) : 759-772.
Rochín-Medina J. J.,Ramírez-Medina H. K.,Rangel-Peraza J. G.,Pineda-Hidalgo K. V.,Iribe-Arellano P. .2018 .Use of whey as a culture medium for Bacillus clausii for the production of protein hydrolysates with antimicrobial and antioxidant activity. Food Science and Technology International, 24(1) : 35-42.
Sorokulova I. B.,Pinchuk I. V.,Denayrolles M.,Osipova I. G.,Huang J. M.,Cutting S. M.,Urdaci M. C. .2008 .The safety of two Bacillus probiotic strains for human use. Digestive diseases and sciences, 53 : 954-963.
Tabandeh F.,Hosseinian Moghaddam,Yakhchali H. R.,Shariati B.,Hamed P.,Mousavian P.,Ghasemi M. T.,F. M. T. .2011 .Fed-batch fermentation of Bacillus clausii for efficient production of alkaline protease using different feeding strategies. Chemical Engineering Communications, 198(9) : 1063-1074.
Urdaci M. C.,Bressollier P.,Pinchuk I. .2004 .Bacillus clausii probiotic strains: antimicrobial and immunomodulatory activities. Journal of clinical gastroenterology, 38 : S86-S90.
Valgas C.,Souza S. M. D.,Smânia E. F.,Smânia A. .2007 .Screening methods to determine antibacterial activity of natural products. Brazilian journal of microbiology, 38 : 369-380.
Zeashan M.,Afzaal M.,Saeed F.,Ahmed A.,Tufail T.,Ahmed A.,Anjum F. M. .2020 .Survival and behavior of free and encapsulated probiotic bacteria under simulated human gastrointestinal and technological conditions. Food science & nutrition, 8, (5) : 2419-2426.
0

Citations

0

Downloads

7

Views